Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026)
Olema Pharmaceuticals' (OLMA) quarterly Prepaid Assets came in at $1.2 million in Q1 2026, up 345.65% year-on-year from $276000.0 in Q1 2025, and down 87.72% on a QoQ basis from $10.0 million in Q4 2025.
Olema Pharmaceuticals (OLMA) Prepaid Assets (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 7 years of Prepaid Assets data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 345.65% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 345.65% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 869.51% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.2 million, down from $10.0 million in the prior quarter.
- Over the last five years, Prepaid Assets for OLMA reached as high as $10.0 million in Q4 2025 and fell as low as $129000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $2.0 million across 5 years, with a median of $1.2 million in 2026.
- Across the five-year window, Prepaid Assets plunged 89.76% in 2023 and surged 1200.84% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $129000.0 in 2022, then soared by 860.47% to $1.2 million in 2023, then fell by 16.63% to $1.0 million in 2024, then soared by 869.51% to $10.0 million in 2025, then plunged by 87.72% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.2 million in Q1 2026, $10.0 million in Q4 2025, and $577000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Olema Pharmaceuticals | 1.21 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 10.02 Mn |
| Sep 30, 2025 | 577,000.00 |
| Jun 30, 2025 | 452,000.00 |
| Mar 31, 2025 | 276,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 887,000.00 |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 274,000.00 |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 129,000.00 |
| Sep 30, 2022 | 2.46 Mn |
| Jun 30, 2022 | 2.32 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 93,000.00 |
| Sep 30, 2021 | 318,000.00 |
| Jun 30, 2021 | 2.71 Mn |